Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS

Key Points

• Goldman Sachs Group Inc. sold 81,540 shares of COMPASS Pathways PLC, decreasing its stake by 77.4%, leaving it with 23,746 shares valued at $68,000.
• Several institutional investors, including Vivo Capital LLC and Nantahala Capital Management LLC, have significantly increased their holdings in COMPASS Pathways, with increases of 109.1% and 182.9% respectively.
• COMPASS Pathways' stock has experienced a 2.4% decline, opening at $5.73, with an average price target of $16.29 from analysts, despite the company reporting a quarterly loss that missed estimates.

Goldman Sachs Group Inc. decreased its stake in shares of COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS - Free Report) by 77.4% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 23,746 shares of the company's stock after selling 81,540 shares during the quarter. Goldman Sachs Group Inc.'s holdings in COMPASS Pathways were worth $68,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vivo Capital LLC boosted its position in shares of COMPASS Pathways by 109.1% during the first quarter. Vivo Capital LLC now owns 3,362,385 shares of the company's stock worth $9,616,000 after acquiring an additional 1,754,385 shares during the last quarter. Nantahala Capital Management LLC boosted its position in shares of COMPASS Pathways by 182.9% during the first quarter. Nantahala Capital Management LLC now owns 2,829,232 shares of the company's stock worth $8,092,000 after acquiring an additional 1,829,232 shares during the last quarter. ARK Investment Management LLC boosted its position in shares of COMPASS Pathways by 4.0% during the first quarter. ARK Investment Management LLC now owns 1,804,803 shares of the company's stock worth $5,162,000 after acquiring an additional 68,601 shares during the last quarter. GMT Capital Corp boosted its position in shares of COMPASS Pathways by 15.1% during the first quarter. GMT Capital Corp now owns 1,781,718 shares of the company's stock worth $5,096,000 after acquiring an additional 233,918 shares during the last quarter. Finally, Woodline Partners LP boosted its position in shares of COMPASS Pathways by 279.9% during the first quarter. Woodline Partners LP now owns 1,754,856 shares of the company's stock worth $5,019,000 after acquiring an additional 1,292,927 shares during the last quarter. Institutional investors own 46.19% of the company's stock.

Analyst Ratings Changes

Several equities analysts have commented on CMPS shares. HC Wainwright lowered their price objective on shares of COMPASS Pathways from $45.00 to $40.00 and set a "buy" rating for the company in a research report on Monday, August 4th. Canaccord Genuity Group reiterated a "buy" rating and set a $15.00 price objective on shares of COMPASS Pathways in a research report on Friday, August 1st. Finally, Evercore ISI reiterated an "in-line" rating and set a $6.00 price objective (down previously from $11.00) on shares of COMPASS Pathways in a research report on Monday, June 23rd. Six investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $16.29.

COMPASS Pathways Stock Down 2.4%

Shares of COMPASS Pathways stock opened at $5.73 on Wednesday. COMPASS Pathways PLC Sponsored ADR has a 1 year low of $2.25 and a 1 year high of $6.61. The stock has a market cap of $549.74 million, a price-to-earnings ratio of -3.11 and a beta of 2.17. The company has a debt-to-equity ratio of 0.16, a current ratio of 8.82 and a quick ratio of 8.82. The firm's 50-day moving average is $4.72 and its two-hundred day moving average is $4.03.

COMPASS Pathways (NASDAQ:CMPS - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates of ($0.37) by ($0.01). As a group, research analysts expect that COMPASS Pathways PLC Sponsored ADR will post -2.33 earnings per share for the current fiscal year.

COMPASS Pathways Profile

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa.

Want to see what other hedge funds are holding CMPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.